This week we were able to join Biocom and Biocom members in Washington DC for Biocom’s Regenerative Medicine Fly-In.
This event “brought 10 participants from seven companies, including researchers, regulatory experts and business executives to Washington to meet with officials at the National Institutes of Health (NIH) and the Food and Drug Administration (FDA), as well as U.S. Representatives Susan Davis, Scott Peters, Lou Correa and Judy Chu. Participants had the unique opportunity to discuss new advances in regenerative medicine and the successes and challenges they face.”
We are always grateful to be able to speak out for our field, as well as to be able to remind our officials that patient care is our top priority! For more information, click here.
